TY - JOUR
TI - Durvalumab for urothelial carcinoma, non‑small cell lung cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2019
ET - 2019/04/24
VL - 42
IS - 3
SP - 103
EP - 104
DO - 10.18773/austprescr.2019.030
LA - eng
UR - https://australianprescriber.tg.org.au/articles/durvalumab-for-urothelial-carcinoma-non-small-cell-lung-cancer.html
KW - Imfinzi
KW - durvalumab
KW - urothelial carcinoma
KW - non-small cell lung cancer
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -